Search

Reports on the various conferences and expositions to be held from February to May 2004 in the pharmaceutical industry. Nasal Drug Delivery Conference on 26th and 27th February 2004; AAPS Workshop on Dissolution from 29th to 31st March 2004; CNA Clinical Trials and Drug Development from 28th to 30th April 2004; European Conference on Drug Delivery and Pharmaceutical Technology between 10th to 12th May 2004.

Presents a calendar of various forums, conferences in the field of pharmaceutical industry from January, 2004 to June, 2004. 18th International Forum Process Analytical Chemistry & Technology (IFPAC/PAT); Dissolution, Bioequivalence, Bioavailability, conference, Philadelphia; International Activated Carbon Conference, Mexico City, Mexico; Respiratory Drug Delivery IX, conference and exhibition, Palm Desert, California; 2004 AAPS National Biotechnology Conference, Boston.

Highlights the November 2003 Innovative Strategies for Kick-Starting Growth, the third-annual Pharmaceutical Roundtable hosted by "The Economist" magazine in the United States. Productivity; Sales and marketing; Public opinion.

Presents a calendar of events for the pharmaceutical industry between December 2003 and May 2004. Schedule of 12th annual conference of portable inhalers at London, UK on 15th and 16th December 2003; Announcement of 'Pharmtechexpo' at Budapest, Hungary between 11-13 February 2004; Interphex 2004 between 16-18 march 2004 at new York, USA.

Informs about the calls for papers by The Professional Analytical and Consulting Services (PAC) for the Winter International Activated Carbon Conference to be held in Mexico City and the 14th Annual International Activated Carbon Conference to be held in Pittsburgh. Dates of the conferences; Specifications for the content of the papers invited.

Reports that Mitch Daniels, former director of the U.S. Office of Management and Budget and Eli Lilly's strategy chief, will present the Hall of Fame keynote address at the Direct Marketing Association's annual conference and exhibition in October 2003. Professional background of Daniels; Topic of Daniels' speech.

Analyses the views raised in the inaugural meeting of the Pharmaceutical Advisory Board founded by the PiR group to provide a forum for leaders representing both emerging and established pharmaceutical companies. Problems of talent transfer from pharma to biotech; Assessment of risk profiles and team dynamics during recruitment process; Need for an attractive remuneration package.

Highlights the pharmaceutical industry's annual direct-to-consumer (DTC) national conference held in Boston, Massachusetts. Role of DTC in improving health care; Topics discussed at the conference; Speakers.

Presents a calendar of events of relevance to the pharmaceutical sector in the U.S. from February to June 2003. PharmaOutsourcing; Informex Trade Show; Parenteral Drug Association Spring Conference; Drug Information Association 39th Annual Meeting.

Reports that International Pharmaceutical Excipients Council of Americas is sponsoring a regulatory affairs conference that will examine regulatory, compendial, business and scientific topics that affect global harmonization and marketability of pharmaceutical excipients.

Provides an overview of the Global Forum on Pharmaceutical AntiCounterfeiting to be held by Reconnaissance International on September 22 to 25, 2002. Forum program; Forum participants; Prevalence of counterfeit pharmaceuticals.

Provides information on the first branding seminar sponsored by the journal 'Pharmaceutical Executives' in April 2002. Topics discussed; List of speakers.

Provides information on the 2002 ePharma Summit which included pharmaceutical marketers, electronic-communications managers and technology providers. Number of attendees; Issues discussed during the event; List of speakers.

Presents information on the 2002 Annual Congress on Drug Discovery Technology in Boston, Massachusetts. Preconference workshops; Conference program; Short courses sponsored by IBC during the final two days of the conference.

Focuses on the BIO CEO & Investor Conference 2002 held at Waldorf=Astoria in New York City in February. Topics discussed at the conference; Participants; Speakers; Details of a presentation that discussed how biotechs must promote themselves responsibly to the media.

Highlights the 12th annual Conference on Pharmaceutical Ingredients and Intermediates (CPhI), held in October 2001 in London, England. Inclusion of Degussa's announcement that its fine chemicals business unit will increase sales; Lonza's plans to expand microbial fermentation manufacturing at its Kourim facility in the Czech Republic.

Comments on the pharmaceutical industry's efforts to mitigate the impact of AIDS in Africa. Highlights of the July 2000 World AIDS Conference; Advice for the industry.

Deals with the remarks of Ventro chief operating officer Robin Abrams about the prospects for electronic commerce during the meeting of the Societe de Chimie Industrielle. Strategy to succeed in the life science products business; Joint venture with E.I. du Pont de Nemours & Co.

Highlights the Interphex USA Conference and Exhibition 2000 of the pharmaceutical industry which will be held at Javits Convention Center in New York City. Major sponsors of the event; Activities during the event.

Highlights the American Society of Hospital Pharmacists (ASHP) convention in Orlando, Florida in December 1999. Report of the Institute of Medicine regarding medical errors; Plans of creating a credentialing program for advance practice of pharmacists; Expansion of the ASHP campaign that promoted health-system pharmacists.

Highlights the fourth international symposium of ChiRex on process development chemistry held in Amelia Island, Florida. Comments from Thomas Crawford, executive development of process development at Pfizer Inc.; Effects of technological advances in the time needed to discover drug candidates; Theme of the symposium; Trend toward greater integration between drug discovery and drug developments.

Provides information on the workplace issues discussed during the California Pharmacy Board forum in September 1999. Views on license reciprocity; Criticism on the pharmacy board; Remarks from Bruce Young, senior vice president of California Retail Association.

Reports on the pharmaceutical highlights of the American College of Cardiology's annual meeting in New Orleans, Louisiana. Favorable results of phase III trials for clot-busting drugs TNK tPA and nPA; Effectiveness of the agents in individuals with normal cholesterol levels who have suffered acute myocardial infarction; Role of lipid-lowering drugs in preventing cardiovascular complications.

Highlights the speakers' remarks during the 1999 Reed Conference of the Massachusetts College of Pharmacy and Allied Health Sciences regarding the issues facing the pharmaceutical industry. Growth potential and earnings in pharmaceutical care and nutraceuticals; Medication errors; Ways in which retail pharmacies can provide their own quality control.

Reports on the Bulk Materials Handling Committee's seminar to discuss controlled feeding of solids in the food pharmaceutical and process industries on November 14, 1997. Topics and subjects covered; Contact information.

Looks at the International Pharmaceutical Excipients Council's (IPEC) role of establishing uniform global standards for pharmaceutical excipients by harmonizing the pharmacopoeias of the United States, Europe and Japan. IPEC as forum where major organizations can share information to improve regulatory policies; Obstacles encountered regarding IPEC membership.

Reports on the 1997 Pharmaceutical Ingredients USA suppliers exhibition held in Philadelphia, Pennsylvania.

Reports that the dermatological benefits of salicylic acid, a beta hydroxy acid, for treating aging skin and acne were presented at the 1996 World Congress of Pharmacy held in Jerusalem.

Reports on the Generic Pharmaceutical Industry Association (GPIA), the National Association of Pharmaceutical Manufacturers (NAPM) and the National Pharmacists Association's (NPA) desire to participate at the International Conference on Harmonization, 1996, an international table where United States, European and Japanese regulators are drafting guidelines to avoid needless duplication of tests for marketing approval.

Announces the name change of the National Drug Trade Conference to the National Conference of Pharmaceutical Associations in 1996. Reason for the move.

Focuses on the annual conference of the American Managed Care Pharmacy Association. Discussion on health-care costs.

Compares the issues tackled during the 1989 and 1995 Pharmacy in the 21st Century Conferences as a means of determining the trends in the pharmaceutical industry. Discussion of issues affecting the future of pharmacy.

Reports on the US Pharmacopoeia open conference. Participants; Discussion of the risks and benefits of medication.

Reports on the Merchandise Expo `94 and the new products exhibited. DuoDerm Hydroactive Gel; DermaSorb Spiral hydrocolloid/Alginate wound dressing; AlgiDerm calcium alginate wound dressing; ProtectAll insulated carrying case; Glucometer encore diabetes care system; Bladder control pads; Intravenous pole; Telescoping hospital bed rests.

Reports on International Pharmaceutical Excipients Council of Americas (IPEC) decision to hold its 1998 annual meeting at WorldPHARM. Scope of WorldPHARM meeting; Advantages from the addition of IPEC program; Goal of the WorldPHARM '98.

Reports on PDA as the official sponsor of WorldPHARM '98. Business enterprises represented by PDA; PDA member Joyce De Young as the Honorary WorldPHARM Advisory Board.

Focuses on the launching of WorldPHARM 98 at the Pharm Tech/BioPharm Conference in Philadelphia, Pasadena. Venue for WorldPharm 98; Representative of WorldPHARM'S sponsoring organizations; Acknowledgement of KPMG Peat Marwick; Emphasis on WorldPHARMS'S unique reach into the pharmaceutical and biopharmaceutical communities.